UA33655A - Method for treating simple and paranoid schizophrenia - Google Patents

Method for treating simple and paranoid schizophrenia

Info

Publication number
UA33655A
UA33655A UA99031571A UA99031571A UA33655A UA 33655 A UA33655 A UA 33655A UA 99031571 A UA99031571 A UA 99031571A UA 99031571 A UA99031571 A UA 99031571A UA 33655 A UA33655 A UA 33655A
Authority
UA
Ukraine
Prior art keywords
haloperidol
paranoid schizophrenia
treating
duration
oral administration
Prior art date
Application number
UA99031571A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Петро Тодорович Петрюк
Петр Тодорович Петрюк
Original Assignee
Харківська Міська Клінічна Психіатрична Лікарня № 15
Харьковская Городская Клиническая Психиатрическая Больница № 15
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківська Міська Клінічна Психіатрична Лікарня № 15, Харьковская Городская Клиническая Психиатрическая Больница № 15 filed Critical Харківська Міська Клінічна Психіатрична Лікарня № 15
Priority to UA99031571A priority Critical patent/UA33655A/en
Publication of UA33655A publication Critical patent/UA33655A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the medicine, namely to the psychiatry and may be used for treating the simple and paranoid schizophrenia. The method for treating the simple and paranoid schizophrenia comprises the use of the central electroanalgesia in the setting of the oral administration of psychotropic agents, namely high daily doses of Haloperidol. In 30 min after the oral administration of Haloperidol in the morning, 10 mg of Haloperidol in tablets is administered followed by the central electroanalgesia in the varying relative pulse duration mode with the increment of the current from 0.8 to 1.2 mA, the pulse rate from 200 to 1000 Hz, their duration from 1.2 to 1.3 ms. The duration of the procedure increases from 45 to 60 min with the course of the treatment comprising 13 daily procedures.
UA99031571A 1999-03-23 1999-03-23 Method for treating simple and paranoid schizophrenia UA33655A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99031571A UA33655A (en) 1999-03-23 1999-03-23 Method for treating simple and paranoid schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99031571A UA33655A (en) 1999-03-23 1999-03-23 Method for treating simple and paranoid schizophrenia

Publications (1)

Publication Number Publication Date
UA33655A true UA33655A (en) 2001-02-15

Family

ID=74196396

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99031571A UA33655A (en) 1999-03-23 1999-03-23 Method for treating simple and paranoid schizophrenia

Country Status (1)

Country Link
UA (1) UA33655A (en)

Similar Documents

Publication Publication Date Title
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
IL113651A0 (en) Pharmaceutical compositions containing alendronate and their use
NZ508526A (en) Opioid formulations for treating pain
PL338982A1 (en) Drug for improving duration of muscle action or for treating muscular disorders or diseases
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
DE60134453D1 (en) Pharmaceutical compositions for the treatment of CNS and other diseases
ATE302003T1 (en) PREPARATIONS CONTAINING APOMORPHINE AND SILDENAFIL AND THEIR USE FOR TREATING ERECTILE DYSFUNCTION
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
DE69613840D1 (en) ORAL DOSAGE FORM AND METHOD FOR TREATING PAIN CONDITIONS IN THE ORAL CAVE
IL140412A0 (en) L-lys -l-glu dipeptides for pharmaceutical preparations
DK0668763T3 (en) Use of Phenserin in the manufacture of drugs for the treatment of cognitive disorders
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
US6143320A (en) Method for the application of an active substance patch for controlling or alleviating an addiction
UA33655A (en) Method for treating simple and paranoid schizophrenia
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
HUP9903679A2 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
UA33739A (en) Method for treating continious schizophrenia
UA33819A (en) Method for treating paranoid shift-like schizophrenia
UA33665A (en) Method for intensive treatment of simple schizophrenia
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
WO2003072019A3 (en) Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
UA38299A (en) METHOD OF INTENSIVE THERAPY OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA
JO2296B1 (en) Substituted pyrroles
UA38381A (en) METHOD OF COMPLEX THERAPY OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA
UA33198A (en) Method for intensive therapy of schizophrenia